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Abstract
Bacteria, as well as higher organisms such as sea anemones or earthworms, have developed sophisticated virulence factors such as the pore-
forming toxins (PFTs) to mount their attack against the host. One of the most fascinating aspects of PFTs is that they can adopt a water-soluble
form at the beginning of their lifetime and become an integral transmembrane protein in the membrane of the target cells. There is a growing
understanding of the sequence of events and the various conformational changes undergone by these toxins in order to bind to the host cell surface,
to penetrate the cell membranes and to achieve pore formation. These points will be addressed in this review.
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doi:10.1016/j.bbamem.2008.01.026well as sea anemones or earthworms, produce toxic substances
able to disrupt cellular membranes [1–3]. These can be small
chemical compounds (cyclodextrin family [4], lipids etc), pep-
tides or large protein assemblies, all produced with the common
aim of altering the lipid bilayer of target cells.
The plasma membrane of a cell is not just a simple physical
barrier that separates the cytoplasm from the outer world but
1612 I. Iacovache et al. / Biochimica et Biophysica Acta 1778 (2008) 1611–1623constitutes one of the most complex components of the cell. The
picture of a membrane composed of a homogeneous lipid mixture
in which proteins are embedded is indeed no longer valid [5,6]. It
has become increasingly apparent that the 2-dimensional com-
partmentalization is an important requirement to fulfill the mul-
tiple functions of the plasma membrane. Proteins cluster into
homo or hetero assemblies within the membrane, lipids undergo
lateral segregation and finally preferential assemblies of lipids
with proteins form. Being highly opportunistic in nature, bacterial
pathogens have learned to use this plasmamembrane organization
and in some instances perturb it [7–9].
Among the toxins produced by bacteria, the largest class is
that of pore-forming toxins (PFTs), which represent some 30%
of all known bacterial toxins [1] and will be the topic of this
review. PFTs are however also produced by higher organisms
like cnidaria, [10], sea anemones (actinoporins) [11], earthworm
(lysenin) [2] and plants (enterolobin) [12]. Within the PFT
family, some sub-families such as that of the cholesterol-
dependent cytolysins (CDC) or the actinoporins can be found.
Although sequence similarities can be found within these fa-
milies, PFTs from different sub-families share no sequence
homology, despite similarities in the mode of action. One of the
most fascinating aspects of these toxins is that they are secreted
as fully soluble proteins yet in their final state, they form a
transmembrane channel in the target cell membrane. This is
achieved by the following common steps: the soluble toxin
diffuses toward the target cell to which it binds via specific
receptors. As will be described below, many PFTs then require
an oligomerization step that is followed by membrane insertion
and channel formation [13]. Interesting new findings have been
made regarding the effects of pore formation in target cells, how
the cell senses the effects of the toxins and subsequently react,
sometimes leading to membrane repair and cell survival. These
topics will not be covered here and the interested reader is
referred to the following recent reviews [14–16].
2. Structural classification of pore-forming toxins
Pore-forming toxins can be classified in more than one-way,
for example according to their pore size or membrane-binding
mode. We prefer a classification according to the type of struc-
ture with which the toxin finally crosses the membrane, i.e. alpha
helical (α-PFT) or ß-barrel (ß-PFT) [17,18]. Interestingly one
reaches the same classification when sorting PFTs based on the
presence or absence of hydrophobic stretches in their primary
sequence. α-PFTs indeed contain stretches of hydrophobicity
that are predicted to be helical and as we will see are able to
span lipid bilayers. In contrast, ß-PFTs are not predicted to be
transmembrane based on the analysis of hydrophobicity. They
however contain pairs of amphipathic ß-strands, which when
combined in multi-protein structures generate a sufficiently hy-
drophobic surface for membrane insertion to occur.
2.1. α-PFT
The α-PFT family includes the colicins produced by Escher-
ichia coli, which are arguably the best-characterized in this family[22–24], actinoporins that are produced by sea anemones [19],
diphtheria toxin produced by Corynebacterium diphtheriae, exo-
toxin A from Pseudomonas aeruginosa [1] and the insecticidal
Cry toxins produced by Bacillus thuringiensis [20,21] , which
received much attention due to their potential role in pest control
in transgenic crops.
2.1.1. Colicins
Colicins are PFTs produced by E. coli and aimed at killing
relatedE. coli [22]. The bacteria expressing the toxin also produce
an immunity protein that protects them from the action of the
toxin [22–24]. After production, the soluble colicins are secreted
in the external medium and upon encounter of the target cells bind
to specific receptors [25–27] and are subsequently translocated
into the periplasm via a variety of mechanisms [13,25,28]. Once
in the periplasmic compartment, some colicins, such as Colicin A
or E1, form pores in the cytoplasmic membrane while others are
translocated into the cytoplasm where they function as DNAse,
RNAse or block protein synthesis [22,23]. It has been shown
recently that endonuclease domains of colicins may interact with
the bacterial cytoplasmic membrane and mediate their own
translocation through the bacterial inner membrane [29,30]. The
structures of various pore-forming colicins have been solved to
atomic resolution [31–33] and reveal the multi-domain structure
of these proteins. As an example, colicin Ia [32] can be divided
into three domains [34]: the translocation domain is formed by 3
helices, one of which extends to the receptor-binding domain.
This receptor-binding domain is formed by a short ß-hairpin and
three short helices. Both domains, and the channel-forming
domain, are connected by the coiled–coil structure (Fig. 1a). The
coil–coiled domain is thought to be involved in bridging the
periplasmic space based on the unusual length of the domain
~160 Å. The pore-forming domain, made up of a bundle of ten α-
helices is a globular domainwith a hydrophobic core composed of
an α-helical hairpin (helices 8 and 9)(Fig. 1b). This α-helical
bundle structure with a central hidden hydrophobic helical hairpin
is common to all pore-forming colicins and is also shared by
completely unrelated but pore-forming proteins, such as the
translocation domain of diphtheria toxin [35]. Unmasking of the
hydrophobic central hairpin, through partial unfolding of the
pore-forming domain is thought to be triggered by a local low pH
at the membrane interface [13,36] although other mechanisms
cannot be excluded. Channel formation however requires inser-
tion not only of the central hydrophobic hairpin but also that of
adjacent helices [23,37,38]. Also multimerization is most likely
required although definite proof is lacking. Unfortunately no
high-resolution structure of the pore configuration is available and
therefore the exact configuration of the helices remains quite
speculative.
2.1.2. Actinoporins
Actinoporins belong to the family of pore-forming toxins
produced by sea anemones [11] that have received increasing
attention in recent years [3]. The best-studied members of this
family are equinatoxin II produced by Actinia equinia and
sticholysin II of Stichodactyla helianthus. Binding of these toxins
to membranes appears to be mediated by lipids [39,40].
Fig. 1. Ribbon representation of the crystal structures of α-PFT; the transmembrane region is colored in violet (a) colicin Ia (PDB entry code 1CII): the T translocation,
R receptor-binding domain and the C channel-forming domains are indicated (b) close-up view of the C pore-forming domain of colicin Ia (c) Equinatoxin II (PDB
entry code 1IAZ) (d) Cry4Aa composed of domains I, II and III (PDB entry code 2C9K) (e) Domain I, the pore-forming domain of Cry4Aa. Figures were produced
with the program PyMol (http://www.pymol.sourceforge.net).
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reveals a β-sandwich flanked on both faces by short α-helices
[39] (as shown for equinatoxin in Fig. 1c). The N-terminal ~30
residues that include one of the α-helices are free to detach from
the core of the protein and insert into the bilayer to form the pore.
Upon insertion the N-terminal helix is extended by 8–9 residues
[41]. In order to form functional pores in the membrane, these
toxins must oligomerize forming ring shaped tetramers. Each
monomer contributes one α-helix to the formation of a 2 nmwide
pore [19].
2.1.3. Insecticidal pore-forming toxins of the Cry family
This family of α-pore-forming toxins has received increasing
attention due to their use as insecticides especially in the trans-
genic crop [42]. As a general mode of action these toxins are
produced during sporulation of the bacterium as inclusion
crystals. Upon ingestion by the insect larvae and under alkaline
conditions in the insect midgut, the crystals dissolve releasing
the monomeric pro-toxins [42]. Cry toxins have been found to
bind to the GPI-anchored insect aminopeptidase N [43] and to
glycolipids in worms [44]. A sequential binding scenario has
also been proposed where the toxin binds to a first receptor for
activation followed by an interaction with a secondary receptor
that relocates the toxin to lipid microdomains that could favor
multimerization [42,45]. Recently however an interesting syn-
ergistic mechanism was proposed where the B. thuringiensis
Cyt1Aa toxin first bound to the target cell membrane and
became the receptor for the Cry11Aa toxin [46]. Although it is
clear that Cry toxins require multimerization, the stochiometry
of the complex is a matter of debate, dimers, trimers, tetramers
and even large multimeric assemblies having been proposed
(reviewed in [47]). Recent 2D crystallization trials showing a
trimeric pore in either a propeller or pinwheel form and which
were interpreted as closed/opened states of the channel seem to
tilt the balance in favor of the trimeric pore assembly [47].
The structure of several monomeric active Cry toxins has
been solved [20,48–51] showing a large protein that, based also
on biochemical evidence, can be divided into three separated
domains (Fig. 1d). The N-terminal, pore-forming, domain I is a
helical globular domain in which helix 5 is strongly hydrophobic
and forms the core of the domain while helices 1–4 and 6–7 form
the outside wall shielding the hydrophobic helix from the
aqueous media [20], a structure reminiscent of that of the pore-
forming domain of colicins (Fig. 1e). Domain II of the protein is
a lectin-like domain composed mainly of β-sheets and is
probably involved in the binding of the protein to the receptor.
The third domain of the protein is composed of a twisted β-
sandwich and its role in the activity of the toxin is not well
understood. It is thought to play a role in the stability of the toxin
and to protect the main body of the protein from proteolytic
activity and it might also have a role in receptor recognition and
binding [48,52].Fig. 2. Ribbon representation of the crystal structures of ß-PFT: the transmembrane r
stem domain (PBD entry code 1T5R) (b) one α-toxin monomer in the oligomer; noted
7AHL) (c) proaerolysin (PDB entry code 1PRE) (d) anthrax PA: one monomer from P
O, where the conserved undecapeptide is colored in blue (PDB entry code 1PFO). Figu2.2. The ß-PFTs
The majority of bacterial PFTs known to date belong to
the ß-PFT class. Members include the large family of the
cholesterol-dependent cytolysins (CDCs) [53], the multiple
PFTs produced by Staphylococcus aureus such as its α-toxin
[54], Bacillus thuringiensis Cyt delta-endotoxins [21] as well as
the translocation subunits of certain AB type toxins including
that of anthrax toxin [55]. The means by which ß-PFT form
transmembrane pores is better understood due to the availability
of structures, not only of the soluble toxin but also of the
transmembrane form solubilized in detergents [56–58]. As for
α-PFTs, ß-PFTs are secreted by bacteria, or other organisms, as
soluble proteins that diffuse in the external medium towards
target cells to which they bind via specific receptors. Once
bound, ß-PFTs must oligomerize, a process favored by the
concentration effect related to the change in dimension between
the extracellular space (3D) and the membrane surface (2D).
Some members of the ß-PFT family require activation by host-
specific proteases in order to be able to oligomerize [59,60]. The
formed oligomer is for most toxins initially not transmembrane
and thus called the prepore [53]. A second series of confor-
mational changes is required for membrane insertion and pore
formation to occur [13]. To date the only high-resolution struc-
ture of a oligomeric pore is that of the Staphylococcal α-toxin
heptamer, the structure of which was solved in detergents [56].
2.2.1. S. aureus PFTs
S. aureus produces a variety of PFTs, including α-toxin
and the leukocidins, which as a family are arguably the best-
characterized PFTs from a structural point of view, since high-
resolution structures are available for the soluble and oligomeric
forms. The leukocidins are bi-component toxins, pore formation
requiring both a so-called class F component and a class S
component [61,62], whereas α-toxin forms homomeric pores
[56]. The structures of two components of the class F proteins,
HlgB from γ-hemolysin [63] and LukF-PV from Panton–
Valentine leukocidin [64] as well as one S component, LukS-PV
[65] have been solved (Fig. 2a). To date no structural infor-
mation of a leukotoxin hetero-oligomer, whose proposed sto-
chiometry varies from 6 to 8 [66–70], is available. In contrast,
whereas the structure of the soluble form is not available for
Staphylococcal α-toxin, that of the heptameric transmembrane
configuration, solubilized in detergent, is. Since all Staphylo-
coccal PFTs are highly homologous, it is believed that the
combined information from the various structures provides an
overall view of the changes that lead to pore formation. We will
first describe the channel structure and subsequently compare it
to that of the soluble toxin.
All attempts to find a proteinaceous or glycolipid receptor
for α-toxin have failed. It has been recently proposed that high
affinity binding of the toxin to the membrane could be mediatedegion is colored in purple (a) the water-soluble LukS-PV monomer with the pre-
are the cap with the amino-latch, the rim and the stem domains (PDB entry code
A63 heptameric prepore is represented (PDB entry code 1TZO) (e) perfringolysin
res were produced with the program PyMol (http://www.pymol.sourceforge.net).
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within sphingomyelin cholesterol microdomains [7]. Once
on the plasma membrane, α-toxin (also called α-hemolysin)
oligomerizes into a circular, water-soluble, heptameric prepore
[63,71,72]. A second conformational change leads to mem-
brane penetration of a fairly small portion of each monomer and
formation of a water-filled transmembrane pore. The struc-
ture of the detergent-solubilized α-toxin heptamer was solved
by X-ray crystallography, with a 1.9 Å resolution [56] (Fig. 3a).
The pore is a mushroom-shaped, hollow heptamer (with overall
dimensions of 100 Å×100 Å), mostly composed of ß-structure
and containing 3 domains (Fig. 2b and Fig. 3a). The cap domain
consists of the ß-sandwich and an amino-latch that provides
additional links between the protomers. Underneath the cap,
the rim domain is located in close proximity of the outer leaflet
of the plasma membrane. The stem domain, or the transmem-
brane ß-barrel pore perforating the membrane, consists of a 14-
stranded ß-barrel to which each protomer contributes an anti-
parallel ß-hairpin. The diameter of the pore varies along its
lumen from 30 Å at the entrance to 22 Å along the stem around
[54]. Although several studies, using crystallography or mass
spectrometry, reported the assembly of a heptameric pore, ato-
mic force microscopy experiments suggested that α-toxin
could also associates into a hexameric pore [73].
The structures of the soluble PFTs, HlgB, LukF and LukF-PV
[63–65] are all very similar to that of the α-toxin protomer
(Fig. 2a). The rim domains are rotated slightly with respect to the
cap domain. The main difference is as expected in the stem
region: in the water-soluble state, this region adopts a 3-stranded
amphipathic β-sheet, where the hydrophobic residues (which
face the lipids in the transmembrane configuration) pack against
the β-sandwich. Another difference between the water-soluble
and membrane forms occurs in the 12 amino terminal residues of
the protein, the so-called N-terminal latch, which form a strand
in the soluble form but displays aperiodic structure in the
channel form.
2.2.2. Aerolysin and related toxins
Aerolysin is a ß-PFT produced by Aeromonas hydrophila.
Related toxins, in terms of sequence and structure, are however
produced by a great variety of organisms: α-toxin from Clos-
tridium septicum [74], ε-toxin by Clostridium perfringens [75],
hydralysins by Cnidaria [10], a hemolytic lectin by the parasitic
mushroom Laetiporus sulphureus [76] and enterolobin by the
seeds of the Brazilian tree Enterolobium contorliquum [77,78].
The best-characterized member however remains aerolysin,
which will thus be described in more detail.
A. hydrophila secretes a precursor toxin, proaerolysin, via a
type II secretion system in the extracellular medium [79] and for
a recent review see [80]. Proaerolysin binds to the target mem-
brane, in a monomeric or dimeric form [81,82], via the specific
interaction with glycosyl phosphatidyl inositol (GPI)-anchored
proteins [83–86]. The glycan core and the N-linked sugar
located on the proteinaceous moiety of the receptors are the
two determinants involved in the binding [86,87]. Proaerolysin
is converted into aerolysin by gut proteases, Aeromonas pro-
teases [88] or members of the furin family of mammalian en-doproteases [89], which remove some 40 amino-acids from the
C-terminus [90]. If the concentration is high enough, aerolysin
will subsequently oligomerize into a heptameric ring [91,92].
The X-ray structure of proaerolysin in the dimeric form revealed
an L-shaped elongated molecule divided into two domains, a
small globular domain, and a large lobe linked together by a long
stretch of residues [93] (Fig. 2c). The globular domain, domain
1, is mainly implicated in binding of the toxin to sugar mo-
difications of the target receptor [86]. The elongated domain of
the protein has been traditionally divided into three distinct
domains that are non-continuous in sequence: domain 2 is
involved in binding to the GPI-anchor [84] and in initiating the
oligomerization process [94]. Domain 3 is responsible to some
degree for monomer–monomer contact in the heptamer [95].
Also it contains a loop shielded against the ß-sheet of the main
body that must move for oligomerization to proceed [96]. Re-
cently, the role of this loop was reinvestigated and it is actually
the part of the protein that inserts into the membrane to form the
transmembrane amphipathic β-barrel [97,98] Finally, domain 4
contains the pro-peptide, which is proteolytically removed upon
activation [99]. The role of this pro-peptide might be to prevent
oligomerization as shown for Clostridial alpha-toxin [100].
No high-resolution structure is available of aerolysin in the
transmembrane state. Cryo-negative staining EM analysis was
however performed on the heptameric form of an aerolysin
mutant [57]. A single point mutation Y221G was found to
convert the wild-type aerolysin hydrophobic heptamer into
water-soluble complex. The molecular envelope obtained at
13 Å revealed a conserved mushroom-shaped soluble heptamer
(Fig. 3b), resembling the previously observed pores of wild-
type aerolysin obtained by 2D crystallography [91] Docking of
the model of the wild-type proaerolysin where the C-terminal
pro-peptide was removed allowed to propose a refined model
for the wild-type heptamer. Although location of domains 1 and
2 in cap of the mushroom was consistent with all experimental
data, position of domain 3 and 4 in the mouth and lumen of the
wild-type pore does not corroborate the finding that only a small
loop in domain 3 is involved in spanning the membrane [97].
Understanding pore formation by members of the aerolysin
family will therefore require further structural analysis of the
channel form.
Interestingly, as mentioned above, a novel class of pore-
forming toxins has been recently discovered in the cnidaria
phylum that belongs to the ß-pore formers and shows a re-
markable structural similarity to aerolysin [10].
2.2.3. The protective antigen of Anthrax toxin
Anthrax toxin, produced by Bacillus anthracis, the causative
agent of anthrax, belongs to the family of AB toxins (for a recent
review see [55]). This ternary toxin consist of two enzymatic A
moieties, Lethal factor (LF) and Edema Factor (EF), and one B
moiety, the Protective Antigen (PA), which binds to the receptors
and translocates the A subunits across the membrane into the
cytoplasm. LF is a Zn2+ protease that cleaves and inactivates
MAP kinase kinases and EF a Ca2+- and calmodulin-dependent
adenylate cyclase [55]. PA, which is of interest to the topic of this
review, binds to one of the two identified receptors, TEM8,
Fig. 3. Ribbon representation of the crystal structures of β-PFT in their transmembrane form; the transmembrane region is colored in violet (a) α-toxin heptamer (PDB
entry code 7AHL) (b) Molecular envelope of aerolysin Y221G heptamer. The image shows a dimer of heptamers joined together by their large base (reproduced with
permission) (c) Prepore PA63 of the anthrax protective antigen (PDB entry code 1TZO) (d) Molecular envelope of the pneumolysin prepore and pore (reproduced with
permission). Figures were produced with the program PyMol (http://www.pymol.sourceforge.net), except (b) and (d).
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phogenesis protein 2 [102]. As aerolysin, PA requires proteolytic
activation. A fragment of 20 kDa is removed from the N-terminus
and the remaining protein named PA63 stays bound to the receptor
and undergoes circularly assembly into a heptameric prepore [55].
The PA prepore acts as the receptor for LF and/or EF [55]. The
complex is then internalized and delivered to endosomes. The
prepore undergoes a pH dependent conformational change that
leads to membrane insertion. LF and EF unfurl and translocate
trough the pore to the cytosolic compartment where they reach
and modify their cytosolic targets [55].
The X-ray structure of the monomeric PA [103] as well as that
of PA bound to its CMG2 receptor [104] displays an elongated
molecule divided in 4 domains (Fig. 2d). Domain 1 contains the
cleavage site for processing PA83 into an activated PA63. Domain
2 contains a large flexible loop named 2ß2–2ß3 that corresponds
to the “to be” amphipathic transmembrane ß-hairpin [105,106].
Domain 3 is thought to participate in the oligomerization step.
Domain 4 is mainly involved in the interaction with the receptor.
The structure of the PA63 heptamer has been solved on its own as
well as bound to the PA binding domains of the receptors
[103,107]. These structures show that the 2ß2–2ß3 loop projects
out of one monomer and inserts into the neighboring monomer
between domains 2 and 4 (Fig. 3c), which both interact with the
receptor. Therefore, for channel formation to occur, separation of
domains 2 and 4 must take place to free this loop. The interface
between domains 2 and 4 contains seven histidine residues that
upon acidification in the endosome luminal will be protonated
leading to the repulsion between the two domains and liberation
of the pore-forming loop. It is interesting to note that cellular
receptors domore than just binding PA to the cells surface. It was
shown that the receptor determines the pH at which the pore-
forming loop will unfold [108,109] and may also serve to orient
PA properly with respect to themembrane [110]. The structure of
the transmembrane form has not been solved. A model has
however been proposed showing a very long ß-barrel of which
only the very end would perforate the membrane, the rest would
bridge the length between the PA binding domain of the receptor
and the membrane surface [104].
2.2.4. Cholesterol-dependent cytolysins (CDCs)
CDCs compose a large family of more than 20 members
[53]. These major virulence factors are secreted by a variety of
Gram-positive bacteria including perfringolysin O (PFO) from
C. perfringens, streptolysin O (SLO) from Streptococcus pyo-
genes, pneumolysin from S. pneumoniae and listeriolysin O
(LLO) from Listeria monocytogenes. CDCs share a high de-
gree of sequence similarity (40–80%) suggesting that they have
similar structures and activity [111].
As the name indicates, CDCs require cholesterol for their
action. The exact step at which cholesterol is required – cell
surface binding, oligomerization or membrane insertion – varies
between CDCs [112]. It was initially thought that cholesterol
was the receptor for all CDCs. PFO indeed directly binds to
cholesterol and even in solution this interaction leads to con-
formational changes throughout the protein that promote mul-
timerization [113]. Cholesterol is however not the receptor forLLO [114] and Streptococcus intermedius Intermedilysin ILY
[8]. ILY was found to bind to human CD59 [8], which is a GPI-
anchored molecule required to prevent the formation of the
complement membrane attack complex (MAC) on cells by
binding complement proteins C8a and C9 [115,116]. Unlike
aerolysin that binds to sugars on GPI-anchored proteins, ILY
binds to the protein itself and more specifically to the same site
on CD59where binding of C8a and C9 occur [8]. However, even
in the case of ILY, cholesterol is required for pore formation
[117]. Possibly due to this requirement for cholesterol, CDCs
were shown to associate with cholesterol-rich lipid microdo-
mains [118,119] and even lead to their aggregation [120].
The most interesting structural aspect of CDCs is that they
form very large pore of ≈300 Å in diameter and are composed
of up to 50 monomers, the number being somewhat variable
[121] as opposed to the above described ß-PFTs. CDCs not only
form oligomers with more protomers than other ß-PFTs but in
addition, each monomer contributes 2 ß-hairpins to the trans-
membrane ß-barrel [121,122], as opposed to one per monomer
for other ß-PFTs, thus leading to ß-barrels composed of some
200 strands [58]!
Two structures of the soluble forms of CDCs are currently
available, that of PFO [123] and that of ILY [124]. As ex-
pected from the sequence similarity, they share a similar glo-
bal architecture: an elongated molecule composed primarily of
β-sheets and divided in 4 domains (Fig. 2e). As in the case of
proaerolysin, at a first glance, one can differentiate an elongated
domain (composed by domains 1, 2 and 4) and a separated
domain (domain 3) that is made up by a β-sheet and several short
α-helices. Domain 4 is involved in binding to cholesterol-rich
membrane domains through the insertion of several loops: a
highly conserved undecapeptide rich in tryptophan residues and 3
hydrophobic short loops called L1, L2 and L3 [125–127]. The
interactions of PFO with cholesterol are crucial since they prime
irreversible conformational changes that are propagated along the
toxin and are important for the prepore to pore conversion [113].
Crystallization of PFO at two different pHs showed that con-
formational changes in domain 3 are connected with those oc-
curring in domain 4 [128].
Domain 3 contains the two segments that will ultimately form
the two transmembrane β-hairpins (TMH1 and TMH2) (Fig. 2e)
[121,122]. TMH1 and TMH2 are interestingly in an α-helical
configuration in the soluble form, thus undergoing a prion like
alpha to beta transition upon pore formation [129]. Pores of
CDCs have at present not been crystallized. Electronmicroscopy
studies have however provided a very clear picture of these
beautifully arranged complexes [58] and suggest conformational
changes that accompany membrane insertion (Fig. 3d).
Pore-forming proteins are not unique to the bacterial world.
The mammalian immune systems utilizes pore formation as a
mean to kill pathogens or infected cells through the action of the
complement cascade, which final steps are the formation of the
membrane attack complex (MAC), or perforin secreted by cyto-
lytic T cells. These proteins share a common MACPF domain,
which was recently solved for two proteins: Plu–MACPF from
Photorhabdus luminescens [130] and the human C8a [131].
Remarkably, the MACPF domain was found to be structurally
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mains, indicating that bacterial and mammalian membranolytic
proteins share a common mechanism for membrane insertion.
3. Membrane insertion of PFTs
Very little is known about this crucial step of the mode of
action of PFTs. As mentioned, α-PFTs contain hydrophobic
helices, the membrane insertion of which, when exposed, is
thought to be spontaneous. In the case of ß-PFTs, oligomeriza-
tion always precedes membrane insertion. What triggers the
prepore to pore conversion however remains largely obscure.
Prepore formation, while described in many ß-PFTs such as
CDCs [53], S. aureus α-toxin [132] or C. septicum α-toxin
[100], was however never observed for aerolysin and it appears
that heptamer formation and membrane insertion are concomi-
tant events [97]. We have indeed proposed that ß-barrel folding
and membrane insertion are coupled as also proposed for the
folding of outer membrane proteins [133].
3.1. Membrane insertion of α-PFTs
As mentioned earlier, the pore-forming domain of colicins
contains a hydrophobic helical hairpin formed by helices 8 and 9.
These are initially hidden within the helical bundle but become
exposed upon partial unfolding of the molecule. Membrane
insertion of these helices leads to the formation of a pore that is
at that stage still closed, the so-called umbrella model [23]. In
the next step of channel formation, the rest of the helices of the
C-domain are thought to insert into the bilayer leading to the open
pore [134]. It is not clear how a monomeric toxin can form a pore
and it has thus been proposed that colicin needs tomultimerize for
pore formation to occur. Recently however, it has been proposed
that the colicin pore is also lined with lipids forming a toroidal
pore complex [135] such as the pores formed by small peptides or
the translocation channel form by diphtheria toxin [136]. Recent
evidence points to this toroidal pore complex as a general
mechanism even in the case of oligomeric toxins assemblies such
as the pores made by actinoporins [137]. In this latter case, the
lipids would play a major role in pore formation and indeed it has
been shown that certain lipids favor pore formation while other
can inhibit the toxin activity, a property that was related with the
capacity of the lipids to favor either positive or negative curvature
[138,139]. While a toroidal pore formed by small pore-forming
peptide is not a stable assembly due to the lack of a rigid structure
connecting the α-helices that span the membrane, in the case of
PFTs, the pores are more stable [13]. This is most probably due in
part to the fact that these helices are kept together by extracellular
interactions. Stability can also be increased by anchoring pores to
the trans-side of the membrane, a mechanism proposed both for
equinatoxin [140] and aerolysin [97] and can also be induced by
designing mutants of the transmembrane helices [36].
3.2. Membrane insertion of ß-PFTs
Also for ß-PFTs, membrane insertion is very poorly un-
derstood. While in the case of α-PFTs pore formation seems tobe driven by an initial insertion of hydrophobic helices in the
case of ß-PFTs, insertion has to be a concerted event. It has been
shown for the protective antigen of anthrax toxin that specific
residues are required to position the ß-hairpin in the good re-
gister through salt bridges [141].
From a sequence analysis of known or predicted transmem-
brane regions in ß-PFTs based on the residues that line the pore
and form the tip of the anti-parallel transmembrane ß-hairpin, a
model has been proposed that would divide the pores into two
categories [97]. In the case of α-toxin of S. aureus, the pore is
lined with short polar residues lacking any charge while the tip
of the hairpin contains three charged residues. It is possible that
the insertion proceeds due to the hydrophobicity of the residues
that will form the external face of the pore in the final structure
while the charged tip is hidden towards the inside of the channel
during membrane penetration. Once on the other side of the
membrane, the charges will anchor the pore in the inserted
conformation. In the case of aerolysin, the inside of the pore is
lined with charged residues except for the tip of the hairpins,
which are hydrophobic [97]. In this case, insertion would be
initiated by the tips of the ß-hairpins, which, once on the other
side, would fold back towards the hydrophobic core of the
membrane anchoring the pore in a rivet like manner [97].
The composition of the plasma membrane could also play a
role in promoting membrane insertion, either by promoting the
oligomerization process as do lipid rafts [9,119,142], or by
promoting the formation of inverted phases [143]. It has indeed
been shown using artificial liposomes that membrane insertion
of aerolysin was favored by lipids such as phosphatidyletha-
nolamine and diacylglycerol [143]. The underlying mechanism
however remains to be unraveled.
4. Conclusion and future perspectives
Pore-forming toxins have long fascinated scientists both
through their structural properties and mode of action [144,
145]. Many cellular processes and defense mechanisms were
unraveled by studying the opportunistic behavior of pathogens
whose toxins have evolved to hijack specific cellular processes
and whose action trigger specific cellular responses [14,146].
From this point of view it is clear that the study of pore-forming
toxins, from bacteria or other organisms, would not only offer
ways to counter attacks but answer more general questions from
a broad spectra of biology.
The newly described structure of Plu–MACPF from Pho-
torhabdus luminescens [130] and the human C8a [131] again
shows that knowledge gained in the pore-forming toxins field
can be broadened and applied to defense mechanism of higher
organisms. Indeed, as mentioned before, pore-forming toxins
are ancient weapons that are not exclusively bacterial but also
found in plants [78], cnidaria [3,10] and mammals [130,131].
While the field is advancing rapidly, there are still some of
the original questions that have not yet received answers or are
subjects of debate. For example, oligomerization is one of the
less understood processes in the mode of action of PFTs. It is not
clear whether this process begins with monomeric species that
dimerizes and then continue through addition of monomers
1620 I. Iacovache et al. / Biochimica et Biophysica Acta 1778 (2008) 1611–1623until the full oligomeric shape is produced or if monomers,
dimers and higher oligomers interact in the formation of the
structure. Understanding the assembly of oligomeric PFTs
would also be informative for the assembly of other multi-
protein complexes such as the chaperone GroEL or the pro-
teasome. What is most crucially lacking however is the high-
resolution structural information on how PFTs interact with
their various types of receptors—lipids, proteins and sugars,
and on how they form the pore and interact with the lipid
membrane. This will require co-crystallization of toxins and
receptors and ideally 2D crystallization of the pores within the
membrane. Therefore the PFT field has yet some challenges
ahead.
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